Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Medicines Contracts With Accession Option 2026-02-23
Germany Medicines With The Active Ingredient Rivaroxaban (atc: B01af01 - In All Power Strengths Except 2.5 Mg Each Divided Oral Dosage Form) 2026-02-23
Germany Open House Discount Contracts 2025-11-eltrombopag 2026-02-23
Germany Medicines With The Active Ingredient Eltrombopag (atc: B02bx05) 2026-02-23
Germany Completion Not Excl. Pharmaceutical Discount Club. According To Section 130a (8) Sgb V By Means Of An Open House Model To The Active Ingredient Omalizumab (atc Code According To Who: R03dx05) 2026-02-23
Germany Completion Not Excl. Pharmaceutical Discount Club. According To Section 130a (8) Sgb V By An Open House Model To The Active Ingredient Brinzolamide/brimonidin (official Atc Code: S01ec24) 2026-02-23
Germany Provision Of Services Related To The Active Substance Certolizumab Pegol Under An Open-house Model, Including The Execution Of Agreements Not Excluding Drug Discount Agreements As Per § 130a Abs. 8 Sgb V. Certolizumab Pegol 2026-02-23
United Kingdom Snbts Blood & Tissue Establishment Computerised System 2026-02-24
Bangladesh Procurement Of Gauge,bandage And Cotton 2026-02-24
Germany Completion Non -existing Discount Agreements According To § 130a Para. 8 Sgb V To The Active Ingredients Mentioned With A Final Option In The Context Of The So -called Open -house Process. 2026-02-24
Whats app